Nicholas Company, Inc. Merck & Co., Inc. Transaction History

Nicholas Company, Inc.

$5.92 Billion
Q1 2024

A detailed history of Nicholas Company, Inc. transactions in Merck & Co., Inc. stock. As of the latest transaction made, Nicholas Company, Inc. holds 460,842 shares of MRK stock, worth $58.3 Million. This represents 1.03% of its overall portfolio holdings.

Number of Shares

460,842

Previous 435,582 5.8%

Holding current value

$58.3 Million

Previous $47.5 Million 28.05%

% of portfolio

1.03%

Previous 0.85%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$113.24 - $131.95 $2.86 Million - $3.33 Million	25,260 Added 5.8%	460,842 $60.8 Million
Q4 2023 Feb 13, 2024	SELL	$100.18 - $109.02 $3,506 - $3,815	-35 Reduced 0.01%	435,582 $47.5 Million
Q3 2023 Feb 13, 2024	SELL	$102.95 - $114.33 $35,003 - $38,872	-340 Reduced 0.08%	435,617 $44.8 Million
Q3 2023 Nov 13, 2023	SELL	$102.95 - $114.33 $35,003 - $38,872	-340 Reduced 0.08%	435,617 $44.8 Million
Q1 2023 Feb 13, 2024	SELL	$102.94 - $114.86 $311,393 - $347,451	-3,025 Reduced 0.69%	435,957 $46.4 Million

Q1 2023 May 11, 2023	SELL	$102.94 - $114.86 $311,393 - $347,451	-3,025 Reduced 0.69%	435,957 $46.4 Million
Q4 2022 Feb 13, 2024	SELL	$87.44 - $112.11 $8.84 Million - $11.3 Million	-101,080 Reduced 18.72%	438,982 $48.7 Million
Q4 2022 Feb 09, 2023	SELL	$87.44 - $112.11 $8.84 Million - $11.3 Million	-101,080 Reduced 18.72%	438,982 $48.7 Million
Q3 2022 Feb 13, 2024	SELL	$84.53 - $94.96 $16,060 - $18,042	-190 Reduced 0.04%	540,062 $46.5 Million
Q3 2022 Nov 14, 2022	SELL	$84.53 - $94.96 $16,060 - $18,042	-190 Reduced 0.04%	540,062 $46.5 Million
Q2 2022 Feb 13, 2024	SELL	$83.49 - $94.64 $14.5 Million - $16.4 Million	-173,405 Reduced 24.3%	540,252 $49.3 Million
Q2 2022 Jul 26, 2022	SELL	$83.49 - $94.64 $14.5 Million - $16.4 Million	-173,405 Reduced 24.3%	540,252 $49.3 Million
Q1 2022 Feb 13, 2024	BUY	$73.51 - $82.4 $20.4 Million - $22.9 Million	278,040 Added 63.83%	713,657 $58.6 Million
Q1 2022 May 11, 2022	SELL	$73.51 - $82.4 $34,549 - $38,728	-470 Reduced 0.07%	713,657 $58.6 Million
Q4 2021 Feb 11, 2022	BUY	$72.28 - $90.54 $3.38 Million - $4.24 Million	46,780 Added 7.01%	714,127 $54.7 Million
Q3 2021 Nov 15, 2021	BUY	$71.68 - $78.83 $2,867 - $3,153	40 Added 0.01%	667,347 $50.1 Million
Q2 2021 Aug 12, 2021	BUY	$70.31 - $77.77 $3.71 Million - $4.11 Million	52,825 Added 8.6%	667,307 $51.9 Million
Q1 2021 May 14, 2021	BUY	$68.86 - $81.11 $3.77 Million - $4.44 Million	54,795 Added 9.79%	614,482 $47.4 Million
Q4 2020 Feb 10, 2021	BUY	$71.77 - $79.65 $4.53 Million - $5.03 Million	63,140 Added 12.72%	559,687 $45.8 Million
Q3 2020 Nov 13, 2020	BUY	$73.18 - $82.95 $1.35 Million - $1.53 Million	18,495 Added 3.87%	496,547 $41.2 Million
Q2 2020 Aug 13, 2020	BUY	$70.42 - $80.13 $2.73 Million - $3.1 Million	38,700 Added 8.81%	478,052 $37 Million
Q1 2020 May 13, 2020	BUY	$63.36 - $87.82 $5.22 Million - $7.23 Million	82,350 Added 23.07%	439,352 $33.8 Million
Q4 2019 Feb 13, 2020	BUY	$77.58 - $87.54 $774,248 - $873,649	9,980 Added 2.88%	357,002 $32.5 Million
Q2 2019 Aug 13, 2019	BUY	$69.84 - $81.59 $2.1 Million - $2.46 Million	30,140 Added 9.51%	347,022 $29.1 Million
Q2 2018 Aug 14, 2018	BUY	$50.83 - $59.72 $8.05 Million - $9.46 Million	158,370 Added 99.91%	316,882 $19.2 Million
Q1 2018 May 14, 2018	SELL	$50.96 - $59.23 $19.4 Million - $22.6 Million	-381,485 Reduced 70.65%	158,512 $8.63 Million
Q4 2017 Feb 14, 2018	BUY	$51.62 - $61.64 $4.02 Million - $4.79 Million	77,785 Added 16.83%	539,997 $30.4 Million
Q2 2017 Aug 11, 2017	BUY	N/A	462,212	462,212 $29.6 Million

Others Institutions Holding MRK

# of Institutions

3,769

Shares Held

1.87B

Call Options Held

17.3M

Put Options Held

14.8M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $320B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nicholas Company, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Nicholas Company, Inc. with notifications on news.

Account

Nicholas Company, Inc. Merck & Co., Inc. Transaction History